Zusammenfassung
Barbital (Veronal), Phenobarbital (Luminal), Solutio Barbamini (Somnifen), Pentobarbital (Nembutal), Pentothiobarbital (Pentothal, Thiopenton), Allobarbital (Dial), Hexobarbital (Evipan), Cyclobarbital (Phanodorm), Methylphenobarbital (Prominal), Heptobarbital (Rutonal), Butobarbital (Soneryl), Barbipyrin (Veramon), Allopyrin (Allonal)
Unangenehme Erscheinungen, die nach Gebrauch von Barbitursäuren vorkommen, können verschiedene Ursachen haben.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
J.A.M.A. 143 (1950) 232.
Ned. Tijdschr. v. Geneesk. 94 (1950) 2767; New. Engl. J. Med. 238 (1948) 272.
Lancet 260 (1951) 1156.
J.A.M.A. 152 (1953) 801.
Lancet (1953I) 1140.
Albahaey, S. 192.
Brit. med. J. (1952 I) 1276.
Münch. med. Wschr. 85 (1938) 1956.
J. Mayr, S. 94.
J.A.M.A. 116 (1941) 700.
Edinb. med. J. 58 (1951) 45.
J.A.M.A. 130 (1946) 1013.
Arch. Derm. Syph. 46 (1942) 386.
J.A.M.A. 116 (1941) 700.
Acta radiol. (Stockholm) 29 (1948) 493.
J.A.M.A. 136 (1947) 397; Minn. Med. 20 (1937) 92.
J.A.M.A. 14 (1953) 600.
Progrès méd. (Paris) 44 (1929) 1685.
Brit. med. J. (1951 I) 383.
Ann. Allergy 7 (1949) 346.
C. Langton Hewer, Recent Advances in Anesthesia and Analgesia, S. 35. London 1948.
Acta clin. belg. 8 (1953) 55.
J.A.M.A. 143 (1950) 232.
Nord. Med. 3 (1951).
S. J. de Vries, Leerboek der Bloedziekten.
Proc. Meet. Mayo Clin. 8 (1933) 713.
Pr. méd. 49 (1941) 961.
Pr. méd. 42 (1934) 1536.
Psych. Neurol. Bl. (Amsterdam) (1935) 409.
Bull. Mém. Hôp. Paris (1934 I) 17; Ned. Tijdschr. v. Geneesk. 85 (1941) 2463.
J. Neuropath, exp. Neurol. 1 (1951) 145.
Ethel Beowning, S. 123.
Nord. Med. 45 (1951) 93.
Davison, S. 283.
J.A.M.A. 147 (1951) 1332.
Ärztl. Wschr. 7 (1952) 562.
West. Virg. med. J. 49 (1953) 254.
Ann. int. Med. 33 (1950) 108.
Arch. Neurol. Psych. 65 (1951) 557.
J.A.M.A. 147 (1951) 1332.
Clin. Science 7 (1948) 249; 8 (1949) 235 und 269; 10 (1951) 185; Sang 25 (1954) 911.
Schweiz. med. Wschr. 73 (1943) 1257.
Ned. Tijdschr. v. Geneesk. 59 (1915) 1500.
Schweiz. med. Wschr. 50 (1950) 177.
Wien. klin. Wschr. 63 (1951) 31.
Yearbook of Drug Therapy 1950, S. 377.
J. Pediat. 36 (1950) 159.
New Engl. J. Med. 242 (1950) 933.
Lancet 262 (1952) 242.
J.A.M.A. 147 (1951) 17.
Lancet 226 (1934) 1230.
J. Mayr, S. 101 und 103.
Ned. Tijdschr. v. Geneesk. 74 (1930) 3628.
Med. Klinik 36 (1940) 961.
Med. Clin. N. Amer. 34 (1950) 346; Ned. Tijdschr. v. Geneesk. 84 (1940) 3887; Ann. int. Med. 27 (1947) 548.
J.A.M.A. 135 (1947) 498; Lancet (1953 II) 600.
Wien. med. Wschr. 101 (1951) 239.
Arch. int. Med. 81 (1948) 605.
Texas St. J. Med. 46 (1950) 520.
J.A.M.A. 139 (1949) 376.
New Engl. J. Med. 242 (1950) 897.
Med. J. Austral. 1 (1949) 68.
Arch. Neurol. Psych. (Chicago) 60 (1948) 484; New Engl. J. Med. 241 (1949) 17; Proc. Meet Mayo Clin. 24 (1949) 483.
J.A.M.A. 147 (1951) 744.
J.A.M.A. 137 (1948) 1031; Ned. Tijdschr. v. Geneesk. 93 (1949) 3434.
Ohio St. med. J. 47 (1951) 1013.
Minerva Med. 43 (1952) 558.
Amer. J. Med. 8 (1950) 124; Acta haemat. (Basel) 6 (1951) 354; Bull. Johns Hopk. Hosp. 91 (1952) 341; Klin. Med. (Wien) 7 (1952) 346; J.A.M.A. 138 (1948) 498, 1148; Schweiz. med. Wschr. 80 (1950) 337; New Engl. J. Med. 241 (1949) 17; Ann.West.Med.Surg.6 (1952) 562; Calif. Med. 78 (1953) 138.
Wien. med. Wschr. 101 (1951) 426.
Schweiz. med. Wschr. 83 (1953) 536.
Arch. Neurol. Psych. (Chicago) 63 (1950) 235.
J. nerv. ment. Dis. 108 (1948) 118.
Pr. méd. 59 (1951) 599.
J.A.M.A. 149 (1952) 1312.
U. S. Armed Forces med. J. 2 (1951) 83; Amer. J. Med. 8 (1950) 124.
J.A.M.A. 148 (1952) 535, 536.
J.A.M.A. 138 (1948) 1012.
Lancet 256 (1949) 517, 519; J.A.M.A. 141 (1949) 18, 263; Amer. J. med. Sci. 4 (1948) 760.
J.A.M.A. 134 (1947) 138.
New Engl. J. Med. 240 (1949) 962.
J. Pediat. 2 (1948) 30.
Canad. Med. Ass. J. 64 (1951) 120.
Brit. med. J. (1948 I) 13.
J. Pediat. 35 (1949) 540.
Siehe 77.
J.A.M.A. 132 (1946) 11 und 13; Acta haemat. (Basel) 5 (1951) 74; Dtsch. med. Wschr. 78 (1953) 1107.
Lancet (1949 I) 517.
New Engl. J. Med. 240 (1949) 962.
Lancet 256 (1949) 59; Amer. J. Med. 4 (1948) 760; Maandschr. Kindergeneesk. 20 (1952) 23.
Lancet (1953 I) 1174.
Ghosh, S. 198.
Albahary, S. 184.
J.A.M.A. 141 (1949) 128, 132.
Bull. Mém. Hôp. Paris (1934 I) 17.
J.A.M.A. 141 (1949) 128, 132.
New Engl. J. Med. 242 (1950) 49.
Arch. int. Med. 82 (1948) 362.
Fuhner, S. 148.
Ghosh, S. 191.
Lancet (1949 I) 517; J. Mayr, S. 102.
Davison, S. 275.
Fuehner, S. 149.
Geburtsh. u. Frauenhk. 12 (1952) 619.
Lancet (1954 I) 19, 21, 102.
Schweiz. med. Wschr. 84 (1954) 446.
New Engl. J. Med. 250 (1954) 197.
Ned. Tijdschr. v. Geneesk. 94 (1950) 1258; Brit. med. J. (1955 I) 645.
Lancet (1940 I) 269.
J.A.M.A. 118 (1942) 1209.
Med. Ann. Columbia 22 (1953) 600.
Arch. int. Med. 94 (1954) 34.
Lancet (1954 I) 58, (1954 II) 939.
Lindemayr, S. 8.
Lindemayr, S. 39.
Ärztl. Wschr. 9 (1954) 1216.
Lancet (1954 II) 737.
Z. Haut-u. Geschl.-krkh. 17, S. 737.
Pr. méd. 62 (1954) 1376.
Schweiz. med. Wschr. 79 (1954) 1215.
Ned. Tijdschr. v. Geneesk. 98 (1954) 3778.
Ugeskr. Laeg. (Dan.) 115 (1953) 1616.
Wien. Arch. Psychol. Psychiatr. Neurol. IV/3 (1954).
Wien. klin. Wschr. H. 12 (1929).
Dtsch. Z. gerichtl. Med. (1937) 256.
Brit. med. J. (1955 I) 1247.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1956 Springer-Verlag
About this chapter
Cite this chapter
Meyler, L. (1956). Medikamente mit dämpfender Wirkung auf das Zentral-Nervensystem. In: Schädliche Nebenwirkungen von Arzneimitteln. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7860-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7860-7_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7861-4
Online ISBN: 978-3-7091-7860-7
eBook Packages: Springer Book Archive